CmaxInsight's "Trigeminal Neuralgia-Epidemiology Forecasting Intelligence" report provides a comprehensive analysis of the Trigeminal Neuralgia epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028.

Our epidemiology services include:
> Incidence and prevalence
> Diagnosis rate, treatment rate and mortality patterns
> Epidemiology-based forecasting and disease trends
> Size of different patient segments in a disease area
> Population based: disease occurrence, co-morbidities and treatment patterns
> Geographic - Regional - Ethnic differences

Along with the epidemiological data, the report also includes:
> Disease overview, causes, symptoms, classification, risk factor, pathophysiology, diagnosis and treatment
> Patient treatment journey
> Treatment algorithm and guidelines
> Assesses the disease risk and burden
> Highlights the unmet needs
> Market driver and barrier
> Growth opportunities and market trend analysis

Methodology
> This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Epidemiology Forecast model analysis by a team of industry experts.
> To generate accurate patient population estimates, utilizes a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.
> All of the sources used to generate the data and analysis have been identified in the report.

Note: Systematic review of the epidemiological literature is also provided for full transparency into research and methods.